Treatment for Gastric Arteriovenous Malformation

Primary Treatment Recommendation

Complete surgical resection is the definitive treatment for gastric AVM, offering immediate elimination of bleeding risk and should be strongly considered as first-line therapy for accessible lesions 1

Digital subtraction angiography (DSA) is the gold standard for pre-treatment assessment, providing superior visualization of feeding vessels, nidus architecture, and venous drainage patterns compared to non-invasive imaging 1
CT angiography can assist with initial assessment but lacks the spatial and temporal resolution needed for definitive treatment planning 1

The American College of Surgeons recommends complete surgical resection via partial gastrectomy as the definitive treatment, providing immediate protection from hemorrhage 1
Pre-operative embolization reduces intraoperative blood loss, surgical complexity, and operative time when used as an adjunct before surgical resection 1
Embolization carries a 2-5% hemorrhagic complication rate, 10-14% risk of new neurological deficits, and approximately 1% mortality 2
Curative embolization rates for AVMs range only 5-20%, making it less reliable as monotherapy 2

Initial 50 μg IV bolus of octreotide followed by continuous infusion at 50 μg/hour for 2-5 days to reduce splanchnic blood flow and control acute hemorrhage 3

Combined preoperative embolization followed by complete surgical excision yields the best outcomes for large or anatomically challenging gastric AVMs 1
Multidisciplinary evaluation involving gastroenterology, interventional radiology, and surgery is essential 1
Treatment planning should be completed before any intervention, as partial treatment without complete obliteration subjects patients to procedural risks without eliminating bleeding risk 4, 5

Never perform partial treatment without a plan for complete obliteration, as this exposes patients to procedural risks while maintaining hemorrhage risk 4, 5
Do not rely on embolization alone as curative therapy, as success rates are only 5-20% for complete obliteration 2
Avoid premature ligation of draining veins during surgery, as this can cause catastrophic bleeding from the nidus 1
Ensure post-treatment imaging confirmation of complete obliteration, as residual AVM carries ongoing bleeding risk 1

Neurological/surgical ICU monitoring for at least 24 hours post-operatively to detect complications including hemorrhage or hemodynamic instability 6
Long-term follow-up imaging with DSA to detect potential recurrence or residual AVM 1

Consider screening for hereditary hemorrhagic telangiectasia (HHT) if multiple vascular malformations are present, as this raises concern for hereditary vascular syndromes 6